OM:IVSO
OM:IVSOAerospace & Defense

Invisio (OM:IVSO): Valuation Perspective Following SEK 190m Intercom Systems Order

Invisio (OM:IVSO) shares are drawing attention after the company secured a SEK 190 million order from an established European client for its Intercom and Dismounted Soldier systems. This signals ongoing demand for its communication technology. See our latest analysis for Invisio. After rallying earlier in the year, Invisio’s share price has softened recently, reflecting some cooling momentum despite that big contract win. Still, the one-year total shareholder return stands at 0.81%, while the...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Promising Brepocitinib Results and Regulatory Progress Might Change The Case For Investing In Roivant Sciences (ROIV)

Earlier this week, Roivant Sciences Ltd. released positive clinical results for brepocitinib in dermatomyositis and reported ongoing regulatory progress for its late-stage pipeline, including expected near-term milestones and strong operational highlights in its latest Form 10-Q. Additionally, the company faced higher net losses and a significant decline in sales compared to the prior year, alongside increased insider share selling and a miss on consensus earnings estimates. The robust data...
OB:VAR
OB:VAROil and Gas

Vår Energi (OB:VAR) Valuation in Focus After Special Dividend Payout Approval

Vår Energi (OB:VAR) just wrapped up an extraordinary general meeting where shareholders gave the green light to a hefty dividend payout for the third quarter. This move highlights management’s focus on rewarding investors directly. See our latest analysis for Vår Energi. On the heels of that dividend approval, Vår Energi’s share price has shown solid momentum in recent weeks, with a 1-month share price return of nearly 7%. This recaptures some ground after a softer start to the year...
NYSE:TGLS
NYSE:TGLSBuilding

Tecnoglass (NYSE:TGLS): Assessing Valuation After Updated Earnings and 2025 Revenue Growth Guidance

Tecnoglass (NYSE:TGLS) just shared its latest earnings and updated revenue outlook, drawing attention from investors. The company posted higher quarterly and year-to-date sales and set expectations for approximately 10% revenue growth in 2025. See our latest analysis for Tecnoglass. Tecnoglass’s upbeat revenue outlook comes after a tough stretch for its share price, with a 1-month share price return of -28.9% and a year-to-date drop of 43%. Despite the recent sell-off, longer-term holders...
ASX:MND
ASX:MNDConstruction

Monadelphous Group (ASX:MND): Valuation in Focus After Upgraded FY26 Revenue Outlook and Strategic Expansion

Monadelphous Group (ASX:MND) saw its shares surge after issuing a new revenue forecast for FY26, pointing to growth of 20 to 25 percent compared to the previous year. This outlook follows a number of fresh contract wins and the acquisition of Kerman Contracting, both of which are expected to expand Monadelphous’s service offerings and customer base. See our latest analysis for Monadelphous Group. Momentum is clearly building for Monadelphous Group, with its recent contract wins and bullish...
NYSE:ASPN
NYSE:ASPNChemicals

Aspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss

Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger annual net loss, including a hefty impairment charge. See our latest analysis for Aspen Aerogels. It’s been a punishing year for Aspen Aerogels after a string of disappointing results and lowered guidance. The share price has tumbled 65% in the last month, and the one-year total shareholder...
SGX:O39
SGX:O39Banks

OCBC (SGX:O39) Valuation: Assessing the Bank After Steady Earnings and Leadership Shift Toward Digital Growth

Oversea-Chinese Banking (SGX:O39) just posted its third quarter results, showing net income holding steady even as net interest income slipped. Investors are also watching a boardroom change aimed at accelerating OCBC's strategic growth and digital transformation. See our latest analysis for Oversea-Chinese Banking. OCBC's share price has gathered steam in recent weeks, adding 10% over the last month alone, as investors respond to its sturdy earnings and evolving digital strategy. This...
TSXV:LMN
TSXV:LMNSoftware

Why Lumine Group (TSXV:LMN) Surged After Rebounding to Profitability in Q3 2025 Earnings

On November 3, 2025, Lumine Group Inc. announced its third-quarter and nine-month 2025 earnings, reporting third-quarter revenue of US$186.71 million and net income of US$24.83 million, both up from the previous year. A particularly interesting detail is the turnaround from a net loss in the prior nine-month period to a significant net income this year, reflecting an improved financial trajectory. We'll explore how the rebound in profitability and revenue growth shapes Lumine Group's...
NasdaqCM:APLT
NasdaqCM:APLTBiotechs

Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision?

Applied Therapeutics released its third quarter 2025 earnings, reporting revenue of US$1 million and a net loss of US$18.99 million, both improved from the previous year; the company also announced Executive Chairman John Johnson's resignation for personal reasons. The sizable reduction in net losses and increased revenue, alongside leadership changes unconnected to business issues, may shape future corporate priorities. We'll explore how Applied Therapeutics' narrowing quarterly losses...
ASX:GNC
ASX:GNCConsumer Retailing

GrainCorp (ASX:GNC) Is Down 9.6% After Profits Fall Despite Higher Sales—Has the Bull Case Changed?

GrainCorp Limited recently reported its full year earnings for the period ended September 30, 2025, with sales rising to A$7,305.7 million from A$6,506.8 million last year, but net income dropping to A$39.9 million from A$61.8 million previously. Despite achieving higher sales, the company saw a significant contraction in bottom-line results, reflecting the impact of challenging global market conditions on profitability. We'll examine how GrainCorp's weaker profit outcome, despite increased...
OM:IMP A SDB
OM:IMP A SDBMedical Equipment

Implantica (OM:IMP A SDB) Is Up 6.0% After Surgeons Endorse RefluxStop at Key Medical Meeting—Has The Bull Case Changed?

Implantica AG recently announced third quarter 2025 earnings, reporting sales of €365,000 and a net loss of €4.34 million, alongside continued rollout of its RefluxStop® device across Europe. Recognition of RefluxStop®’s real-world success by leading acid reflux surgeons at the 2025 European Foregut Society Annual Meeting demonstrates growing clinical confidence in the device’s impact on GERD treatment. We'll explore how strong clinical adoption at a major European conference shapes...
OB:VEND
OB:VENDInteractive Media and Services

Vend Marketplaces (OB:VEND) Valuation in Focus as Share Issue Deadline Approaches

Vend Marketplaces (OB:VEND) has set November 13, 2025, as the deadline for its ongoing share issue, giving eligible A shareholders one last chance to buy in before the subscription period closes. This update carries weight for existing investors because the completion of the share issue could influence the company’s capital structure and how the market perceives its shares. See our latest analysis for Vend Marketplaces. The share price has pulled back over the past three months, with a 90-day...